Oral Leukoplakia
33
7
9
11
Key Insights
Highlights
Success Rate
73% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
12.1%
4 terminated out of 33 trials
73.3%
-13.2% vs benchmark
6%
2 trials in Phase 3/4
45%
5 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (33)
Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions
Comparison of Topical Photodynamic Therapy With Topical Calcipotriol in Management of Oral Leukoplakia
Unveiling the Protein Expression Patterns in Oral Lichen Planus and Leukoplakia Through Comparative Salivary Proteomics
Evaluation of the Chemo-preventive Effect of Combined Topical and Systemic Metformin on Oral Leukoplakia
Efficacy of Topical Coenzyme Q10 and Curcumin for Oral Leukoplakia Treatment
Evaluation of Artificial Intelligence in Diagnosis and Risk Assessment of Oral Potentially Malignant Disorders
Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia
Fenretinide Mucoadhesive Patch: Evaluation of Oral Cancer Prevention Efficacy in Adults With Premalignant Oral Lesions.
Biomarkers for Oral Cancer
SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography
Saliva and Plasma Exosomes for Oral Leukoplakia Malignant Transformation Diagnosis and Oral Cancer Prognosis Monitoring
Identification of Oral Lesions Through an Autofluorescence System
Analyzing Handprint Patterns to Predict Oral Cancer Risks: A Comparative Study
Intra and Extra Oral Inspection of Oral Mucosa
Intralesional 5-fluorouracil Injection for the Treatment of Oral Leukoplakia
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Diagnostic Accuracy of Salivary Gamma-synuclein in Oral Malignant and Premalignant Lesions
Candida Associated Cytokines in Oral Leukoplakia